What is the Panacea Biotec Ltd share price today?

The share price of NSE:PANACEABIO-EQ on 01 Oct 2026 (as of 15:04:29 IST) is ₹357.85.

What is the NSE:PANACEABIO-EQ 52 week high low price?

Over the past 52 weeks (as of 01 Oct 2026), the NSE:PANACEABIO-EQ 52 week high low range shows a high of ₹647 and a low of ₹292.4.

What is the Panacea Biotec Ltd market cap?

As on 01 Oct 2026, Panacea Biotec Ltd market cap is ₹22381000000.

What is the shareholding pattern of Panacea Biotec Ltd Stock?

The shareholding pattern of Panacea Biotec Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 72.48% Foreign Institutional Investors (FII): 2.31% Domestic Institutional Investors (DII): 2.25% Mutual Funds: 0% Retail & Others: 22.96% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Panacea Biotec Ltd?

The Price-to-Earnings (PE) ratio of Panacea Biotec Ltd is 0, and the Price-to-Book (PB) ratio is 2.1728, as on 01 Oct 2026.

Panacea Biotec Share Price

359.40+9.85 (+2.82%)

-18.36% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

1 Day

+2.82%

1 Week

+4.10%

1 Month

-9.62%

3 Month

-36.27%

6 Month

+0.18%

YTD

-4.49%

1 Year

-18.36%

5 Year

+33.63%

10 Year

+231.86%

Max

+9115.38%

YTD

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

348.80

335.00

332.00

292.39

High

366.00

396.95

565.55

647.00

About

Panacea Biotec Limited is one of India’s leading research-based biotechnology companies engaged in the business of research, development, manufacture and marketing of vaccines in India and international markets. The company Read more

Pharmaceuticals & Drugs

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

SUNPHARMANSE

DIVISLABNSE

TORNTPHARMNSE

ZYDUSLIFENSE

LAURUSLABSNSE

CIPLANSE

DRREDDYNSE

MANKINDNSE

AUROPHARMANSE

LUPINNSE

PANACEABIONSE

LTP

1W Low

1W High

Market cap (₹)

1727.3-32.7 (-1.86%)

1725.50

1776.60

4,24,466Cr

9028.5-311.5 (-3.34%)

9028.50

9431.50

2,46,222Cr

4575-81.9 (-1.76%)

4551.80

4682

1,76,301Cr

1125.7+8.2 (0.73%)

1107.30

1139.80

1,12,818Cr

2023.9-12.7 (-0.62%)

2007.80

2069.20

1,10,823Cr

1306+5 (0.38%)

1300.20

1333.30

1,07,447Cr

1213.1+16.1 (1.35%)

1196.90

1250.70

1,03,471Cr

2319-49.5 (-2.09%)

2317.50

2426.80

97,850Cr

1665-28 (-1.65%)

1660.10

1715

96,836Cr

1945.7-10.8 (-0.55%)

1925.70

1964.90

89,629Cr

356.45+11.2 (3.24%)

335

366

2,138Cr

Panacea Biotec Share Price

359.40+9.85 (+2.82%)

-18.36% past 1 Year

Financial overview

Compounded Sales Growth

10 years0%

5 years0%

3 years12%

Last year14%

Compounded Profit Growth

10 years-

5 years-

3 years-

Last year18%

Stock Price CAGR

10 years12%

5 years5%

3 years27%

1 year-21%

Return on Equity

10 years21%

5 years65%

3 years-1%

Last year-1%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
0%	0%	12%	14%
-	-	-	18%
12%	5%	27%	-21%
21%	65%	-1%	-1%

Peer Comparison

Symbol

SUNPHARMA

DIVISLAB

TORNTPHARM

ZYDUSLIFE

LAURUSLABS

CIPLA

DRREDDY

MANKIND

AUROPHARMA

LUPIN

PANACEABIO

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
1,727.3	₹424466 Cr	35.09	12.07	62.82	₹11479 Cr
9,028.5	₹246222 Cr	84.18	34.04	128.41	₹2568 Cr
4,575	₹176301 Cr	80.83	16.72	97.06	₹2163 Cr
1,125.7	₹112818 Cr	25	9.42	62.53	₹5040 Cr
2,023.9	₹110823 Cr	101.36	6.8	29.25	₹889 Cr
1,306	₹107447 Cr	31.88	9.77	57.87	₹3879 Cr
1,213.1	₹103471 Cr	32.11	5.32	63.99	₹4196 Cr
2,319	₹97850 Cr	47.9	13.75	71.08	₹1913 Cr
1,665	₹96836 Cr	26.08	17.95	96.84	₹3505 Cr
1,945.7	₹89629 Cr	16.21	30.95	154.35	₹5333 Cr
356.45	₹2138 Cr	—	0.38	4.16	-₹5 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

Name

Net Revenue

Other Income

Total Revenue

Total Expenditure

Operating Profit

Interest Expense

PBT

Net Profit

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021	Mar 2021	Dec 2020	Sep 2020	Jun 2020	Mar 2020	Dec 2019	Sep 2019	Jun 2019	Mar 2019	Dec 2018	Sep 2018	Jun 2018
₹200 Cr	₹167 Cr	₹165 Cr	₹141 Cr	₹167 Cr	₹133 Cr	₹163 Cr	₹147 Cr	₹116 Cr	₹136 Cr	₹151 Cr	₹143 Cr	₹129 Cr	₹129 Cr	₹115 Cr	₹105 Cr	₹111 Cr	₹141 Cr	₹156 Cr	₹232 Cr	₹132 Cr	₹168 Cr	₹142 Cr	₹182 Cr	₹133 Cr	₹125 Cr	₹168 Cr	₹125 Cr	₹126 Cr	₹123 Cr	₹110 Cr	₹120 Cr	₹99 Cr
₹4 Cr	₹3 Cr	₹2 Cr	₹6 Cr	₹6 Cr	₹9 Cr	₹4 Cr	₹5 Cr	₹4 Cr	₹11 Cr	₹6 Cr	₹3 Cr	₹6 Cr	₹15 Cr	₹14 Cr	₹10 Cr	₹12 Cr	₹4 Cr	₹2 Cr	₹2 Cr	₹3 Cr	₹5 Cr	₹2 Cr	₹2 Cr	₹1 Cr	₹18 Cr	₹3 Cr	₹3 Cr	₹5 Cr	₹51 L	₹3 Cr	₹2 Cr	₹3 Cr
₹204 Cr	₹169 Cr	₹167 Cr	₹148 Cr	₹172 Cr	₹141 Cr	₹167 Cr	₹152 Cr	₹120 Cr	₹147 Cr	₹156 Cr	₹146 Cr	₹135 Cr	₹144 Cr	₹129 Cr	₹116 Cr	₹123 Cr	₹145 Cr	₹158 Cr	₹234 Cr	₹136 Cr	₹173 Cr	₹144 Cr	₹184 Cr	₹134 Cr	₹143 Cr	₹171 Cr	₹129 Cr	₹131 Cr	₹123 Cr	₹114 Cr	₹122 Cr	₹102 Cr
₹202 Cr	₹172 Cr	₹162 Cr	₹167 Cr	₹176 Cr	₹168 Cr	₹165 Cr	₹149 Cr	₹138 Cr	₹151 Cr	₹160 Cr	₹156 Cr	₹149 Cr	₹144 Cr	₹134 Cr	₹119 Cr	₹201 Cr	₹182 Cr	₹155 Cr	₹237 Cr	₹145 Cr	₹179 Cr	₹172 Cr	₹155 Cr	₹122 Cr	₹158 Cr	₹142 Cr	₹142 Cr	₹114 Cr	₹271 Cr	₹137 Cr	₹144 Cr	₹129 Cr
₹10 Cr	₹5 Cr	₹14 Cr	-₹11 Cr	₹4 Cr	-₹18 Cr	₹12 Cr	₹12 Cr	-₹10 Cr	₹5 Cr	₹6 Cr	-₹33 L	-₹4 Cr	₹9 Cr	₹5 Cr	₹7 Cr	-₹68 Cr	-₹26 Cr	₹14 Cr	₹8 Cr	₹2 Cr	₹6 Cr	₹17 Cr	₹40 Cr	₹24 Cr	-₹5 Cr	₹40 Cr	-₹3 Cr	₹28 Cr	-₹135 Cr	₹29 Cr	-₹8 Cr	-₹13 Cr
₹1 Cr	₹1 Cr	₹2 Cr	₹2 Cr	₹86 L	₹1 Cr	₹99 L	₹98 L	₹87 L	₹82 L	₹85 L	₹91 L	₹1 Cr	₹1 Cr	₹96 L	₹1 Cr	₹1 Cr	₹31 Cr	₹52 Cr	₹50 Cr	₹48 Cr	₹47 Cr	₹11 Cr	₹48 Cr	₹45 Cr	₹44 Cr	₹47 Cr	₹41 Cr	₹41 Cr	₹26 Cr	-₹14 Cr	₹29 Cr	₹25 Cr
₹4 Cr	-₹1 Cr	₹6 Cr	-₹19 Cr	₹7 Cr	-₹4 L	₹4 Cr	₹5 Cr	-₹17 Cr	-₹2 Cr	-₹2 Cr	-₹8 Cr	₹13 Cr	₹18 Cr	₹22 Cr	₹23 Cr	-₹51 Cr	₹1608 Cr	-₹49 Cr	-₹53 Cr	-₹57 Cr	-₹53 Cr	-₹40 Cr	-₹19 Cr	-₹33 Cr	-₹59 Cr	-₹18 Cr	-₹71 Cr	-₹24 Cr	₹187 Cr	-₹9 Cr	-₹99 Cr	-₹31 Cr
₹2 Cr	-₹1 Cr	₹4 Cr	-₹14 Cr	₹4 Cr	-₹2 Cr	₹4 Cr	₹5 Cr	-₹16 Cr	-₹2 Cr	-₹2 Cr	-₹8 Cr	₹11 Cr	-₹13 Cr	₹19 Cr	₹16 Cr	-₹56 Cr	₹1237 Cr	-₹49 Cr	-₹53 Cr	-₹57 Cr	-₹54 Cr	-₹40 Cr	-₹19 Cr	-₹34 Cr	-₹70 Cr	-₹21 Cr	-₹75 Cr	-₹28 Cr	₹186 Cr	-₹16 Cr	-₹98 Cr	-₹35 Cr

Balance Sheet

Consolidated

Standalone

₹

Name

Equity And Liabilities

Share Capital

Share Warrants & Outstandings

Total Reserves

Reserve excluding Revaluation Reserve

Revaluation reserve

Shareholder's Funds

Minority Interest

Secured Loans

Unsecured Loans

Deferred Tax Assets / Liabilities

Other Long Term Liabilities

Long Term Trade Payables

Long Term Provisions

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Contingent Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Capital Work in Progress

Non Current Investments

Long Term Investment

Long Term Loans & Advances

Other Non Current Assets

Total Non-Current Assets

Current Assets Loans & Advances

Currents Investments

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Miscellaneous Expenses not written off

Total Assets

Book Value

Adjusted Book Value

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010	Mar 2009	Mar 2008	Mar 2007
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹6 Cr	₹6 Cr	₹6 Cr	₹6 Cr	₹6 Cr	₹6 Cr	₹6 Cr	₹6 Cr	₹6 Cr	₹6 Cr	₹22 Cr	₹22 Cr	₹6 Cr	₹6 Cr	₹6 Cr	₹6 Cr	₹7 Cr	₹7 Cr	₹7 Cr	₹7 Cr
₹0	₹0	₹0	₹0	₹0	₹0	₹32 Cr	₹0	₹0	₹0	₹0	₹10 L	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹829 Cr	₹829 Cr	₹836 Cr	₹837 Cr	₹871 Cr	-₹235 Cr	₹161 Cr	₹344 Cr	₹303 Cr	₹350 Cr	₹426 Cr	₹449 Cr	₹507 Cr	₹620 Cr	₹869 Cr	₹648 Cr	₹694 Cr	₹610 Cr	₹689 Cr	₹530 Cr
₹829 Cr	₹829 Cr	₹836 Cr	₹837 Cr	₹871 Cr	-₹235 Cr	₹161 Cr	₹344 Cr	₹303 Cr	₹350 Cr	-₹33 Cr	-₹11 Cr	₹79 Cr	₹203 Cr	₹441 Cr	₹648 Cr	₹694 Cr	₹610 Cr	₹689 Cr	₹530 Cr
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹459 Cr	₹459 Cr	₹427 Cr	₹417 Cr	₹428 Cr	₹0	₹0	₹0	₹0	₹0
₹835 Cr	₹835 Cr	₹842 Cr	₹844 Cr	₹877 Cr	-₹229 Cr	₹199 Cr	₹350 Cr	₹309 Cr	₹356 Cr	₹449 Cr	₹471 Cr	₹513 Cr	₹626 Cr	₹875 Cr	₹654 Cr	₹701 Cr	₹617 Cr	₹696 Cr	₹536 Cr
-₹6 Cr	-₹4 Cr	-₹4 Cr	-₹3 Cr	-₹3 Cr	-₹3 Cr	-₹3 Cr	-₹3 Cr	-₹3 Cr	₹11 Cr	₹1 Cr	₹3 Cr	₹5 Cr	₹7 Cr	₹7 Cr	₹1 Cr	₹5 Cr	₹3 Cr	₹0	₹0
₹0	₹0	₹0	₹18 L	₹24 L	₹675 Cr	₹584 Cr	₹9 Cr	₹560 Cr	₹705 Cr	₹866 Cr	₹722 Cr	₹582 Cr	₹688 Cr	₹510 Cr	₹422 Cr	₹508 Cr	₹484 Cr	₹207 Cr	₹12 L
₹24 Cr	₹22 Cr	₹21 Cr	₹20 Cr	₹34 Cr	₹60 Cr	₹30 Cr	₹37 Cr	₹10 Cr	₹9 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹2 Cr	₹3 Cr	₹2 Cr	₹199 Cr	₹219 Cr	₹191 Cr	₹213 Cr
₹23 Cr	₹23 Cr	₹23 Cr	₹20 Cr	-₹24 Cr	-₹15 L	-₹2 Cr	-₹20 Cr	-₹10 Cr	-₹18 Cr	₹50 L	₹48 L	₹52 L	₹48 L	₹21 Cr	₹76 Cr	₹71 Cr	₹33 Cr	₹60 Cr	₹38 Cr
₹1 Cr	₹11 Cr	₹22 Cr	₹32 Cr	₹46 Cr	₹194 Cr	₹87 Cr	₹4 Cr	₹4 Cr	₹5 Cr	₹48 Cr	₹15 Cr	₹3 Cr	₹4 Cr	₹2 Cr	₹0	₹0	₹0	₹0	₹0
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹14 Cr	₹0	₹0	₹0	₹0	₹0
₹37 Cr	₹47 Cr	₹199 Cr	₹198 Cr	₹29 Cr	₹31 Cr	₹43 Cr	₹40 Cr	₹27 Cr	₹18 Cr	₹184 Cr	₹180 Cr	₹180 Cr	₹171 Cr	₹171 Cr	₹3 Cr	₹0	₹0	₹0	₹0
₹85 Cr	₹104 Cr	₹265 Cr	₹271 Cr	₹85 Cr	₹960 Cr	₹741 Cr	₹70 Cr	₹591 Cr	₹719 Cr	₹1100 Cr	₹918 Cr	₹767 Cr	₹865 Cr	₹720 Cr	₹503 Cr	₹778 Cr	₹736 Cr	₹458 Cr	₹251 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹190 Cr	₹226 Cr	₹146 Cr	₹177 Cr	₹235 Cr	₹247 Cr	₹199 Cr	₹270 Cr	₹277 Cr	₹249 Cr	₹188 Cr	₹209 Cr	₹252 Cr	₹176 Cr	₹122 Cr	₹97 Cr	₹147 Cr	₹162 Cr	₹110 Cr	₹125 Cr
₹118 Cr	₹105 Cr	₹128 Cr	₹116 Cr	₹503 Cr	₹187 Cr	₹242 Cr	₹585 Cr	₹242 Cr	₹238 Cr	₹94 Cr	₹195 Cr	₹252 Cr	₹50 Cr	₹135 Cr	₹102 Cr	₹6 Cr	₹7 Cr	₹18 Cr	₹17 Cr
₹0	₹0	₹0	₹0	₹0	₹0	₹4 Cr	₹69 Cr	₹165 Cr	₹191 Cr	₹192 Cr	₹296 Cr	₹321 Cr	₹274 Cr	₹250 Cr	₹364 Cr	₹0	₹0	₹0	₹0
₹42 Cr	₹36 Cr	₹36 Cr	₹37 Cr	₹36 Cr	₹13 Cr	₹178 Cr	₹14 Cr	₹11 Cr	₹12 Cr	₹2 Cr	₹6 Cr	₹2 Cr	₹10 Cr	₹10 Cr	₹13 Cr	₹178 Cr	₹311 Cr	₹142 Cr	₹103 Cr
₹349 Cr	₹367 Cr	₹309 Cr	₹330 Cr	₹774 Cr	₹447 Cr	₹622 Cr	₹938 Cr	₹696 Cr	₹689 Cr	₹475 Cr	₹706 Cr	₹827 Cr	₹510 Cr	₹517 Cr	₹576 Cr	₹332 Cr	₹481 Cr	₹270 Cr	₹245 Cr
₹1262 Cr	₹1301 Cr	₹1412 Cr	₹1443 Cr	₹1735 Cr	₹1177 Cr	₹1559 Cr	₹1356 Cr	₹1592 Cr	₹1774 Cr	₹2025 Cr	₹2099 Cr	₹2112 Cr	₹2008 Cr	₹2119 Cr	₹1734 Cr	₹1815 Cr	₹1837 Cr	₹1424 Cr	₹1032 Cr
₹416 Cr	₹367 Cr	₹369 Cr	₹656 Cr	₹368 Cr	₹407 Cr	₹367 Cr	₹404 Cr	₹379 Cr	₹364 Cr	₹354 Cr	₹354 Cr	₹35 Cr	₹29 Cr	₹19 Cr	₹14 Cr	₹59 Cr	₹51 Cr	₹32 Cr	₹18 Cr
₹24 Cr	₹22 Cr	₹21 Cr	₹20 Cr	₹34 Cr	₹820 Cr	₹742 Cr	₹646 Cr	₹941 Cr	₹994 Cr	₹1088 Cr	₹1095 Cr	₹1060 Cr	₹979 Cr	₹877 Cr	₹862 Cr	₹707 Cr	₹703 Cr	₹399 Cr	₹213 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹1369 Cr	₹1328 Cr	₹1312 Cr	₹1331 Cr	₹1314 Cr	₹1266 Cr	₹1282 Cr	₹1393 Cr	₹1606 Cr	₹1600 Cr	₹1620 Cr	₹1633 Cr	₹1698 Cr	₹1694 Cr	₹1639 Cr	₹1040 Cr	₹974 Cr	₹903 Cr	₹606 Cr	₹405 Cr
₹809 Cr	₹777 Cr	₹743 Cr	₹731 Cr	₹692 Cr	₹658 Cr	₹625 Cr	₹587 Cr	₹657 Cr	₹599 Cr	₹549 Cr	₹489 Cr	₹422 Cr	₹540 Cr	₹444 Cr	₹355 Cr	₹282 Cr	₹221 Cr	₹156 Cr	₹110 Cr
₹560 Cr	₹551 Cr	₹569 Cr	₹600 Cr	₹622 Cr	₹609 Cr	₹657 Cr	₹806 Cr	₹949 Cr	₹1001 Cr	₹1071 Cr	₹1144 Cr	₹1276 Cr	₹1154 Cr	₹1195 Cr	₹685 Cr	₹691 Cr	₹681 Cr	₹450 Cr	₹295 Cr
₹100 Cr	₹94 Cr	₹75 Cr	₹28 Cr	₹5 Cr	₹21 Cr	₹10 Cr	₹8 Cr	₹8 Cr	₹9 Cr	₹105 Cr	₹98 Cr	₹104 Cr	₹125 Cr	₹56 Cr	₹37 Cr	₹162 Cr	₹178 Cr	₹207 Cr	₹131 Cr
₹7 L	₹7 L	₹7 L	₹7 L	₹7 L	₹7 L	₹6 Cr	₹5 Cr	₹5 Cr	₹7 Cr	₹5 Cr	₹10 Cr	₹16 Cr	₹17 Cr	₹31 Cr	₹57 Cr	₹73 Cr	₹70 Cr	₹4 Cr	₹1 L
₹7 L	₹7 L	₹7 L	₹7 L	₹7 L	₹7 L	₹6 Cr	₹5 Cr	₹5 Cr	₹7 Cr	₹5 Cr	₹10 Cr	₹16 Cr	₹17 Cr	₹31 Cr	₹57 Cr	₹73 Cr	₹70 Cr	₹4 Cr	₹1 L
₹22 Cr	₹27 Cr	₹242 Cr	₹228 Cr	₹21 Cr	₹18 Cr	₹188 Cr	₹13 Cr	₹28 Cr	₹22 Cr	₹237 Cr	₹262 Cr	₹275 Cr	₹266 Cr	₹294 Cr	₹57 Cr	₹0	₹0	₹0	₹0
₹7 Cr	₹3 Cr	₹97 L	₹4 Cr	₹84 Cr	₹6 Cr	₹60 L	₹1 Cr	₹5 Cr	₹10 Cr	₹1 Cr	₹1 Cr	₹35 L	₹2 Cr	₹7 Cr	₹3 Cr	₹0	₹0	₹0	₹0
₹749 Cr	₹725 Cr	₹927 Cr	₹874 Cr	₹745 Cr	₹666 Cr	₹875 Cr	₹848 Cr	₹1028 Cr	₹1071 Cr	₹1475 Cr	₹1573 Cr	₹1739 Cr	₹1574 Cr	₹1617 Cr	₹920 Cr	₹936 Cr	₹929 Cr	₹677 Cr	₹428 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹10 Cr	₹3 Cr	₹40 Cr	₹13 Cr	₹5 Cr	₹0	₹0	₹0	₹2 Cr	₹27 L	₹4 Cr	₹5 Cr	₹0	₹6 Cr	₹2 Cr	₹9 L	₹2 L	₹0	₹11 Cr	₹0
₹193 Cr	₹214 Cr	₹178 Cr	₹202 Cr	₹213 Cr	₹174 Cr	₹148 Cr	₹81 Cr	₹334 Cr	₹316 Cr	₹305 Cr	₹310 Cr	₹220 Cr	₹268 Cr	₹385 Cr	₹411 Cr	₹458 Cr	₹451 Cr	₹215 Cr	₹209 Cr
₹74 Cr	₹73 Cr	₹57 Cr	₹60 Cr	₹82 Cr	₹85 Cr	₹69 Cr	₹89 Cr	₹136 Cr	₹142 Cr	₹142 Cr	₹99 Cr	₹95 Cr	₹70 Cr	₹68 Cr	₹276 Cr	₹108 Cr	₹120 Cr	₹146 Cr	₹92 Cr
₹64 Cr	₹107 Cr	₹122 Cr	₹226 Cr	₹583 Cr	₹136 Cr	₹90 Cr	₹23 Cr	₹23 Cr	₹14 Cr	₹23 Cr	₹52 Cr	₹25 Cr	₹39 Cr	₹16 Cr	₹49 Cr	₹47 Cr	₹75 Cr	₹155 Cr	₹166 Cr
₹46 Cr	₹16 Cr	₹12 Cr	₹8 Cr	₹9 Cr	₹16 Cr	₹336 Cr	₹273 Cr	₹10 Cr	₹175 Cr	₹9 Cr	₹9 Cr	₹9 Cr	₹6 Cr	₹11 Cr	₹8 Cr	₹4 Cr	₹4 Cr	₹3 Cr	₹3 Cr
₹127 Cr	₹164 Cr	₹76 Cr	₹52 Cr	₹59 Cr	₹64 Cr	₹42 Cr	₹41 Cr	₹59 Cr	₹56 Cr	₹67 Cr	₹50 Cr	₹25 Cr	₹44 Cr	₹19 Cr	₹71 Cr	₹263 Cr	₹248 Cr	₹217 Cr	₹135 Cr
₹513 Cr	₹576 Cr	₹485 Cr	₹562 Cr	₹951 Cr	₹474 Cr	₹683 Cr	₹508 Cr	₹565 Cr	₹703 Cr	₹549 Cr	₹526 Cr	₹373 Cr	₹434 Cr	₹501 Cr	₹814 Cr	₹879 Cr	₹898 Cr	₹747 Cr	₹604 Cr
₹164 Cr	₹209 Cr	₹176 Cr	₹233 Cr	₹177 Cr	₹27 Cr	₹61 Cr	-₹430 Cr	-₹131 Cr	₹14 Cr	₹75 Cr	-₹180 Cr	-₹454 Cr	-₹76 Cr	-₹15 Cr	₹238 Cr	₹547 Cr	₹417 Cr	₹477 Cr	₹359 Cr
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹20 L	₹10 Cr	₹55 L	₹70 L
₹1262 Cr	₹1301 Cr	₹1412 Cr	₹1443 Cr	₹1735 Cr	₹1177 Cr	₹1559 Cr	₹1356 Cr	₹1592 Cr	₹1774 Cr	₹2025 Cr	₹2099 Cr	₹2112 Cr	₹2008 Cr	₹2119 Cr	₹1734 Cr	₹1815 Cr	₹1837 Cr	₹1424 Cr	₹1032 Cr
₹136	₹136	₹137	₹138	₹143	-₹37	₹27	₹57	₹50	₹58	-₹4	-₹1	₹14	₹34	₹73	₹107	₹105	₹91	₹104	₹82
₹136	₹136	₹137	₹138	₹143	-₹37	₹27	₹57	₹50	₹58	-₹4	-₹1	₹14	₹34	₹73	₹107	₹105	₹91	₹104	₹82

Cash Flow

Consolidated

Standalone

₹

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Cash & Cash Equivalent on Amalgamation / Take over / Merger

Effect of Foreign Exchange Fluctuations

Closing Cash & Cash Equivalent

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010	Mar 2009	Mar 2008	Mar 2007
-₹7 Cr	-₹8 Cr	₹1 Cr	₹13 Cr	₹1449 Cr	-₹145 Cr	-₹177 Cr	₹46 Cr	-₹66 Cr	-₹67 Cr	-₹19 Cr	-₹99 Cr	-₹111 Cr	-₹253 Cr	-₹255 Cr	₹154 Cr	₹113 Cr	-₹87 Cr	₹188 Cr	₹212 Cr
₹17 Cr	-₹10 Cr	-₹6 Cr	-₹96 Cr	-₹1455 Cr	₹231 Cr	₹253 Cr	-₹71 Cr	₹167 Cr	₹150 Cr	₹149 Cr	₹167 Cr	₹60 Cr	₹161 Cr	₹200 Cr	₹72 Cr	-₹42 Cr	₹283 Cr	₹40 Cr	₹25 Cr
₹14 Cr	-₹9 Cr	₹10 Cr	-₹337 Cr	₹301 Cr	₹22 Cr	-₹97 Cr	₹127 Cr	₹21 Cr	₹43 Cr	-₹58 Cr	-₹25 Cr	₹107 Cr	₹68 Cr	₹288 Cr	-₹127 Cr	₹4 Cr	-₹177 Cr	-₹126 Cr	-₹13 Cr
₹23 Cr	-₹26 Cr	₹6 Cr	-₹420 Cr	₹295 Cr	₹108 Cr	-₹22 Cr	₹103 Cr	₹122 Cr	₹126 Cr	₹72 Cr	₹43 Cr	₹56 Cr	-₹24 Cr	₹233 Cr	₹99 Cr	₹75 Cr	₹19 Cr	₹102 Cr	₹225 Cr
₹17 Cr	-₹27 Cr	₹3 Cr	-₹422 Cr	-₹108 Cr	₹107 Cr	-₹30 Cr	₹105 Cr	₹118 Cr	₹131 Cr	₹91 Cr	₹37 Cr	₹54 Cr	-₹24 Cr	₹228 Cr	₹78 Cr	₹62 Cr	-₹7 Cr	₹67 Cr	₹157 Cr
-₹40 Cr	₹65 Cr	₹7 Cr	₹430 Cr	₹1283 Cr	-₹48 Cr	-₹35 Cr	-₹5 Cr	₹55 Cr	-₹26 Cr	₹16 Cr	-₹37 Cr	-₹38 Cr	-₹61 Cr	-₹124 Cr	₹12 Cr	-₹117 Cr	-₹115 Cr	-₹384 Cr	₹172 Cr
-₹1 Cr	-₹3 Cr	-₹3 Cr	-₹18 Cr	-₹1176 Cr	-₹47 Cr	₹91 Cr	-₹101 Cr	-₹164 Cr	-₹107 Cr	-₹117 Cr	-₹70 L	-₹30 Cr	₹105 Cr	-₹134 Cr	-₹85 Cr	₹28 Cr	₹160 Cr	₹221 Cr	-₹235 Cr
-₹25 Cr	₹35 Cr	₹7 Cr	-₹10 Cr	-₹2 Cr	₹12 Cr	₹26 Cr	-₹2 Cr	₹9 Cr	-₹2 Cr	-₹10 Cr	-₹85 L	-₹14 Cr	₹20 Cr	-₹29 Cr	₹5 Cr	-₹27 Cr	₹38 Cr	-₹96 Cr	₹94 Cr
₹82 Cr	₹47 Cr	₹40 Cr	₹50 Cr	₹52 Cr	₹40 Cr	₹14 Cr	₹16 Cr	₹7 Cr	₹10 Cr	₹20 Cr	₹21 Cr	₹35 Cr	₹15 Cr	₹44 Cr	₹40 Cr	₹68 Cr	₹30 Cr	₹125 Cr	₹28 Cr
₹0	₹0	₹0	₹0	₹0	-₹11 L	₹24 L	-₹36 L	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹4 L	₹0	₹30,000	-₹40,000	-₹1 L	₹0	₹0	₹0	₹0	₹0	₹1 L	₹0	₹2 L	₹11 L	₹35 L	-₹17 L	-₹77 L	₹42 L	₹8 L	₹3 Cr
₹57 Cr	₹82 Cr	₹47 Cr	₹40 Cr	₹50 Cr	₹52 Cr	₹40 Cr	₹14 Cr	₹16 Cr	₹7 Cr	₹10 Cr	₹20 Cr	₹21 Cr	₹35 Cr	₹15 Cr	₹44 Cr	₹40 Cr	₹68 Cr	₹30 Cr	₹125 Cr

Fundamental Ratios

Consolidated

Standalone

No results found

Panacea Biotec Share Price

359.40+9.85 (+2.82%)

-18.36% past 1 Year

Shareholding summary

Promoters

72.48%

FII

2.31%

DII

2.25%

Others

22.96%

Promoters

FII

DII

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
72.48%	72.48%	72.48%	72.48%	72.48%	72.48%
2.31%	1.60%	1.36%	1.06%	0.79%	1.16%
2.25%	1.96%	1.85%	1.80%	1.52%	1.49%
0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
22.96%	23.96%	24.31%	24.66%	25.21%	24.87%

Bulk & block deals

Name

Microcurves Trading Private Limited

Junomoneta Finsol Private Limited

Nk Securities Research Private Limited

Hrti Private Limited

Dipan Mehta Commodities Private Limited

Elixir Wealth Management Private Limited

Qe Securities Llp

Jump Trading Financial India Private Limited

Clt Research Tech Private Ltd

Microcurves Trading Private Limited

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
09 Jun 2026	Purchase	60.49 Cr	₹626.42	9.66 L	Bulk	1.576673	NSE
09 Jun 2026	Purchase	35.35 Cr	₹623.60	5.67 L	Bulk	0.925389	NSE
09 Jun 2026	Purchase	33.19 Cr	₹624.46	5.32 L	Bulk	0.867815	NSE
09 Jun 2026	Purchase	26.09 Cr	₹617.87	4.22 L	Bulk	0.689373	NSE
09 Jun 2026	Purchase	26.28 Cr	₹624.39	4.21 L	Bulk	0.68723	NSE
09 Jun 2026	Purchase	25.93 Cr	₹624.37	4.15 L	Bulk	0.678062	NSE
09 Jun 2026	Purchase	25.03 Cr	₹621.99	4.02 L	Bulk	0.656917	NSE
09 Jun 2026	Purchase	23.77 Cr	₹624.67	3.81 L	Bulk	0.621229	NSE
09 Jun 2026	Purchase	22.40 Cr	₹623.76	3.59 L	Bulk	0.586196	NSE
09 Jun 2026	Sell	60.51 Cr	₹626.61	9.66 L	Bulk	1.576673	NSE

Insider trading & SAST

Client name

Nosheen Sheikh

Dr Rajesh Jain

Rajesh Jain Huf

Rajesh Jain (Huf)

Dr. Rajesh Jain

Nosheen Sheikh

Sandeep Jain

Rajesh Jain

Sandeep Jain

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal value	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
25 Aug 2026	Employees Immediate Relative	Disposal	0.004898	0	12.29 L	₹409.64	3 K	20 Aug 2026	Market Sale	0	Insider Trading	—	Equity
24 Jul 2026	Other	Acquisition	0.33	—	0	—	2 L	12 Jun 2026	-	—	SAST	10(6)	—
07 Jul 2026	Promoter	Acquisition	0.09	—	0	—	2 L	12 Jun 2026	—	—	SAST	10(5)	—
16 Jun 2026	Promoter Group	Acquisition	0.326527	0.33	0	—	2 L	12 Jun 2026	Gift	2,00,000	Insider Trading	—	Equity Shares
16 Jun 2026	Promoter	Disposal	0.326527	49	0	—	2 L	12 Jun 2026	Gift	3,00,17,312	Insider Trading	—	Equity Shares
03 Oct 2025	Employees Immediate Relative	Acquisition	0.004898	0	12.20 L	₹406.78	3 K	30 Sep 2025	Market Purchase	3,000	Insider Trading	—	Equity Shares
02 Jan 2025	Promoter & Director	Disposal	0.008163	15.27	20.45 L	₹409.06	5 K	31 Dec 2024	Market Sale	93,51,924	Insider Trading	—	Equity Shares
31 Dec 2024	Promoter & Director	Disposal	0.016326	15.28	42.50 L	₹425.04	10 K	27 Dec 2024 - 30 Dec 2024	Market Sale	93,56,924	Insider Trading	—	Equity Shares
30 Dec 2024	Director	Acquisition	0.004898	0	13.65 L	₹454.90	3 K	26 Dec 2024	Market Purchase	3,000	Insider Trading	—	Equity Shares
25 Dec 2024	Promoter & Director	Disposal	0.008163	15.29	21.31 L	₹426.23	5 K	24 Dec 2024	Market Sale	93,66,924	Insider Trading	—	Equity Shares

Panacea Biotec Share Price

Price Analysis

Share Price Live Stats

Share Market Cap & Key Ratios Overview

About

Stock Analysis (SWOT)

QVT

Peer Stocks

Panacea Biotec Share Price

Panacea Biotec Share Price

Financial overview

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Peer Comparison

Profit & Loss

Balance Sheet

Cash Flow

Fundamental Ratios

Panacea Biotec Share Price

Panacea Biotec Share Price

Oscillators

Moving averages

Panacea Biotec Share Price

Shareholding summary

Shareholding Pattern

Bulk & block deals

Insider trading & SAST

Panacea Biotec Share Price

Corporate Actions

Company details

Panacea Biotec Share Price

Corporate filings & documents

Announcements

Annual reports

Concalls & investor presentations

Panacea Biotec Share Price

News

Panacea Biotec secures Rs 78.24 crores UNICEF polio vaccine supply award

Panacea Biotec files appeal against fourth industrial tribunal award, court grants interim relief

Panacea Biotec partners Denstar Project to expand dengue vaccine licensing in Africa

Panacea Biotec Receives CMSS Award Letter for Rs 20.79 Crore Td Vaccine Supply Contract.

Panacea Biotec Tribunal Order Cancels Rs 329 Crore Tax Demand

Panacea Biotec Reports Strong Q3 EBITDA Growth to Rs 11.70 Crores, Margin at 7.11% YoY.

Panacea Biotec Q3FY26 Earnings: Revenue Up YoY, Net Profit Slightly Down.

NCPHP Issues Non-Compliance Notice to Panacea Biotec; GMP Certifications Revoked

Panacea Biotec completes Phase III trial enrolment for DengiAll dengue vaccine, eyes 2027 launch.

Panacea Biotec Completes Enrollment of 10,335 Participants in Phase III Dengue Vaccine DengiAll Trial.

Panacea Biotec Secures UNICEF Contract Enhancement Boosting Vaccine Supply Value by $8.93 Million for 2026-2027.

Devender Gupta, CFO and Head IT, resigns from Panacea Biotec effective December 15, 2025

Panacea Biotec Reports Q2 EBITDA Loss of 17.80 Crores

Panacea Biotec Q2 FY26 results: Net loss widens, revenue declines year-on-year.

Panacea Biotec secures Rs 39.57 crore order for Easyfive-TT vaccine supply in 2026-2027

Panacea Biotec files counterclaims in USD 70 lakh arbitration over COVID-19 tech transfer at LCIA

Panacea Biotec secures Rs 127.20 crore contract for polio vaccine supply to CMSS

Panacea Biotec: Co'S Wholly-Owned Subsidiary, Panacea Biotec Pharma Ltd., Launches India’S First 100% Toxin-Free Baby Care Line “Nikomom” And Infant Milk Substitute “Staart Prime” For The Domestic Market

Panacea Biotec: Co Has Exceptional Item Of 11.30 Crores Rupees || Q1 Loss Before Tax 4.80 Crores Rupees Vs Loss 19.80 Crores (Yoy)

Panacea Biotec: Q1 Cons Net Profit 4.10 Crores Rupees Vs Loss 15.80 Crores (Yoy) || Q1 Revenue 170.00 Crores Rupees Vs 116.00 Crores (Yoy)

Panacea Biotec Ltd Share Price Today

Panacea Biotec Quick Links

Other Stocks

Calculators

Brokerage Calculator

Stock Average Calculator

MTF Calculator

Margin Calculator

Span Margin Calculator